Radiation and drug therapies, and leukemia.
D000970:Antineoplastic Agents / Q000009:adverse effects; D001554:Benzene / Q000009:adverse effects; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002701:Chloramphenicol / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007938:Leukemia / Q000139:chemically induced* / Q000209:etiology*; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced; D007951:Leukemia, Myeloid / Q000139:chemically induced; D007953:Leukemia, Radiation-Induced; D008558:Melphalan / Q000009:adverse effects; D009101:Multiple Myeloma / Q000188:drug therapy; D010653:Phenylbutazone / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011087:Polycythemia Vera / Q000532:radiotherapy
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D010672:Phenytoin; D002701:Chloramphenicol; D003520:Cyclophosphamide; D010653:Phenylbutazone; D001554:Benzene; D008558:Melphalan